...
首页> 外文期刊>BJU international >Initial clinical evaluation of a new pneumatic intracorporeal lithotripter.
【24h】

Initial clinical evaluation of a new pneumatic intracorporeal lithotripter.

机译:新型气动体内碎石机的初步临床评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE To test the clinical efficacy of the StoneBreaker(TM) (LMA Urology, Gland, Switzerland), a novel device which is much more compact and ergonomic than other current intracorporeal pneumatic lithotripters, and more powerful, generating contact pressures of up to 2.9 MPa, thereby enabling better pneumatic fragmentation and removal of stones during percutaneous nephrostolithotomy (PCNL), ureteroscopic stone fragmentation (USF) and vesical stone lithotripsy (VL). PATIENTS AND METHODS We prospectively evaluated 102 patients, comprising 49 PCNLs, 48 USFs and 5 VLs, treated using the StoneBreaker. The stone size, position, number of shocks required to fragment the stone to effect complete clearance, and degree of retropulsion were documented in each case; any evidence of urothelial trauma was noted. RESULTS All stones were satisfactorily fragmented and all patients rendered stone-free. Very few shocks were required, and documented retropulsion was minor. There was no evidence of consequential urothelial trauma at the end of any procedure. CONCLUSION The StoneBreaker appears to be a safe, effective, robust and compact device for intracorporeal lithotripsy.
机译:目的为了测试StoneBreaker™(LMA Urology,Gland,Switzerland)的临床疗效,这种新型装置比其他目前的体内气动碎石机更紧凑,更符合人体工程学,并且功能更强大,可产生高达2.9 MPa的接触压力,从而在经皮肾镜切开术(PCNL),输尿管镜碎石术(USF)和膀胱结石碎石术(VL)时能更好地进行气动碎石和清除结石。患者和方法我们对使用StoneBreaker治疗的102例患者进行了前瞻性评估,包括49例PCNL,48例USF和5例VL。在每种情况下,都记录了石头的大小,位置,将石头打碎以实现完全清除所需的冲击次数以及反冲程度;记录了尿路上皮损伤的任何证据。结果所有结石均令人满意地碎裂,所有患者均无结石。只需要很少的冲击,并且记录的反冲很小。没有证据表明在任何手术结束后都会发生尿路上皮损伤。结论StoneBreaker似乎是一种用于体内碎石术的安全,有效,坚固且紧凑的设备。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号